Randomised controlled trial: Compared with low-dose losartan, high-dose losartan decreases risk of death or hospital admission for heart failure in people with heart failure who are intolerant to ACE inhibitors

Comment

. 2010 Apr;15(2):51-2.

doi: 10.1136/ebm1051.

Affiliations

¹ David Braley Cardiac, Vascularand Stroke Research Institute,McMaster University and Hamilton Health Sciences, Hamilton General Hospital Campus, 237 Barton Street E, Hamilton, Ontario L8L 2X2, Canada. robert.mckelvie@phri.ca

Comment

Robert McKelvie. Evid Based Med. 2010 Apr.

. 2010 Apr;15(2):51-2.

doi: 10.1136/ebm1051.

¹ David Braley Cardiac, Vascularand Stroke Research Institute,McMaster University and Hamilton Health Sciences, Hamilton General Hospital Campus, 237 Barton Street E, Hamilton, Ontario L8L 2X2, Canada. robert.mckelvie@phri.ca

No abstract available

Comment on

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.
Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, Riegger GA, Malbecq W, Smith RD, Guptha S, Poole-Wilson PA; HEAAL Investigators. Konstam MA, et al. Lancet. 2009 Nov 28;374(9704):1840-8. doi: 10.1016/S0140-6736(09)61913-9. Epub 2009 Nov 16. Lancet. 2009. PMID: 19922995 Clinical Trial.